Role of nanotechnologies against infectious diseases: The paradigm of mycobacterium tuberculosis. perspectives for prevention, diagnosis and treatment

Matteo Morandi, Maurizio Sanguinetti, Giovanni Delogu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Tuberculosis (TB) still represents one of the most overshadowing public health issues, particularly in developing countries. The efforts that are currently being made by the scientific community are many and sprout on various fronts, but can be divided in three basic avenues: development of new vaccines for prevention, generation of new and advanced diagnostic tools, and finally improvement of the chemotherapy. An "outside-the-box" approach is hence needed to develop new and improved instruments to fight Mycobacterium tuberculosis, the causative agent of TB. Cutting-edge technologies, such as nanotechnologies, can provide innovative and powerful tools to conquer this ancient infectious disease. Here, some notable examples of how nanotechnologies have entered in infectious diseases field will be presented, discussing how the "white plague," namely the TB, can represent a paradigm of a complex infectious disease whose several aspects must be kept in consideration.

Original languageEnglish
Pages (from-to)134-138
Number of pages5
JournalNanoscience and Nanotechnology Letters
Volume6
Issue number2
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Nanotechnology
Chemotherapy
Vaccines
Public health
Developing countries

Keywords

  • Diagnosis
  • Drug Delivery.
  • Mycobacterium Tuberculosis
  • Nanoparticles
  • Point of Care
  • Vaccines

ASJC Scopus subject areas

  • Materials Science(all)

Cite this

Role of nanotechnologies against infectious diseases : The paradigm of mycobacterium tuberculosis. perspectives for prevention, diagnosis and treatment. / Morandi, Matteo; Sanguinetti, Maurizio; Delogu, Giovanni.

In: Nanoscience and Nanotechnology Letters, Vol. 6, No. 2, 02.2014, p. 134-138.

Research output: Contribution to journalArticle

@article{47aa8c0344e4413ea657a2cb3e491537,
title = "Role of nanotechnologies against infectious diseases: The paradigm of mycobacterium tuberculosis. perspectives for prevention, diagnosis and treatment",
abstract = "Tuberculosis (TB) still represents one of the most overshadowing public health issues, particularly in developing countries. The efforts that are currently being made by the scientific community are many and sprout on various fronts, but can be divided in three basic avenues: development of new vaccines for prevention, generation of new and advanced diagnostic tools, and finally improvement of the chemotherapy. An {"}outside-the-box{"} approach is hence needed to develop new and improved instruments to fight Mycobacterium tuberculosis, the causative agent of TB. Cutting-edge technologies, such as nanotechnologies, can provide innovative and powerful tools to conquer this ancient infectious disease. Here, some notable examples of how nanotechnologies have entered in infectious diseases field will be presented, discussing how the {"}white plague,{"} namely the TB, can represent a paradigm of a complex infectious disease whose several aspects must be kept in consideration.",
keywords = "Diagnosis, Drug Delivery., Mycobacterium Tuberculosis, Nanoparticles, Point of Care, Vaccines",
author = "Matteo Morandi and Maurizio Sanguinetti and Giovanni Delogu",
year = "2014",
month = "2",
doi = "10.1166/nnl.2014.1701",
language = "English",
volume = "6",
pages = "134--138",
journal = "Nanoscience and Nanotechnology Letters",
issn = "1941-4900",
publisher = "American Scientific Publishers",
number = "2",

}

TY - JOUR

T1 - Role of nanotechnologies against infectious diseases

T2 - The paradigm of mycobacterium tuberculosis. perspectives for prevention, diagnosis and treatment

AU - Morandi, Matteo

AU - Sanguinetti, Maurizio

AU - Delogu, Giovanni

PY - 2014/2

Y1 - 2014/2

N2 - Tuberculosis (TB) still represents one of the most overshadowing public health issues, particularly in developing countries. The efforts that are currently being made by the scientific community are many and sprout on various fronts, but can be divided in three basic avenues: development of new vaccines for prevention, generation of new and advanced diagnostic tools, and finally improvement of the chemotherapy. An "outside-the-box" approach is hence needed to develop new and improved instruments to fight Mycobacterium tuberculosis, the causative agent of TB. Cutting-edge technologies, such as nanotechnologies, can provide innovative and powerful tools to conquer this ancient infectious disease. Here, some notable examples of how nanotechnologies have entered in infectious diseases field will be presented, discussing how the "white plague," namely the TB, can represent a paradigm of a complex infectious disease whose several aspects must be kept in consideration.

AB - Tuberculosis (TB) still represents one of the most overshadowing public health issues, particularly in developing countries. The efforts that are currently being made by the scientific community are many and sprout on various fronts, but can be divided in three basic avenues: development of new vaccines for prevention, generation of new and advanced diagnostic tools, and finally improvement of the chemotherapy. An "outside-the-box" approach is hence needed to develop new and improved instruments to fight Mycobacterium tuberculosis, the causative agent of TB. Cutting-edge technologies, such as nanotechnologies, can provide innovative and powerful tools to conquer this ancient infectious disease. Here, some notable examples of how nanotechnologies have entered in infectious diseases field will be presented, discussing how the "white plague," namely the TB, can represent a paradigm of a complex infectious disease whose several aspects must be kept in consideration.

KW - Diagnosis

KW - Drug Delivery.

KW - Mycobacterium Tuberculosis

KW - Nanoparticles

KW - Point of Care

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=84894200647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894200647&partnerID=8YFLogxK

U2 - 10.1166/nnl.2014.1701

DO - 10.1166/nnl.2014.1701

M3 - Article

AN - SCOPUS:84894200647

VL - 6

SP - 134

EP - 138

JO - Nanoscience and Nanotechnology Letters

JF - Nanoscience and Nanotechnology Letters

SN - 1941-4900

IS - 2

ER -